In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘Genomics’ clear

  • Dr. Stacy Gray and Dr. Katherine Janeway studied websites offering products or services related to "personalized cancer medicine." Their research showed online marketing to consumers often failed to explain the limits of the genetic tests.

Tags: Genomics, Genetics

  • Dr. Edward J. Benz, Jr. and Dr. Katherine Janeway commented on the benefit of President Obama’s Precision Medicine Initiative that will benefit research at Dana-Farber.

Tags: Genomics, Genetics

  • Cambridge-based Foundation Medicine is bringing high-tech tools to the battle against cancer. Founded in 2009 by leaders in genome technology including Dana-Farber, the company is analyzing patients' tumors for the entire coding sequence of 200-plus genes known to be altered in human cancers.

Tags: Genomics

  • Dr. David Williams talks about gene therapy in Bubble Boy Syndrome, a rare, immune deficiency disease.

Tags: BasicResearch, Genomics, ImmuneSystem

  • Dana-Farber has launched an extensive research project into cancer genomics.

Tags: Genomics

  • Dr. Bruce E. Johnson said researchers at Foundation Medicine in Cambridge, Mass., have been routinely testing for certain "alterations" in cancer cells to help target treatments and new technologies.

Tags: Genomics, TargetedTherapy

  • Rafael Irizarry, PhD, co-led a new study investigating all stages and types of cancers that appear to share a telltale signature of widespread changes to the epigenome.


Tags: BasicResearch, Genomics

  • Epigenetics was the subject of a particularly interesting session, held on April 1st, at a meeting of the American Association for Cancer Research in Chicago. James Bradner, MD, described how his group has shown that a substance known as JQ1, which inhibits an epigenetic regulator called BRD4, blocks the activity of a gene by the name of Myc.

Tags: Genomics

  • Dr. David Steensma comments on genomic studies cataloging the mutations that drive endometrial cancer and acute myeloid leukemia.

Tags: Genomics, Leukemia

  • Hospitals are using DNA sequencing to generate better treatments and diagnoses for patients, including Dana-Farber, which offers adult patients a test for almost 500 gene variations. Dr. Barrett Rollins say cancer is among the most promising targets because it is essentially a disease in which damaged genes let cells grow without restraint.

Tags: Genomics

Showing 1-10 of 36 items